R-Zero: Funding, Investors & Team (Sep 2026)
The first biosafety technology firm, R-Zero, is committed to making the shared indoor environments safer, healthier, and more effective. We create cutting-edge biosafety solutions that are both efficient and cutting-edge, enabling a better standard of health and safety in the built environment. To enable any firm to evaluate and manage indoor health with a new degree of sophistication and ease, we are developing the first continuous, automated disinfection ecosystem. Thousands of individuals around the nation are now safe thanks to our environmentally friendly, IoT-enabled disinfection technologies. R-Zero, which was established in April 2020, has the support of the Mayo Clinic as well as top venture capital firms and industry experts in the fields of sports, hospitality, health, and impact investing.
R-Zero has raised $252M across 3 funding rounds on record, the most recent a Series C of $105M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
R-Zero Company Profile and Key Stats
Latest funding round on record: Feb 2023.
R-Zero Funding Rounds
R-Zero raised $41.5M in an undisclosed round announced in Jun 2021.
11 months later, a Series C of $105M was announced in May 2022.
9 months later, a Series C of $105M was announced in Feb 2023.
R-Zero Founders and Leadership Team
No contact details are on record for this team yet.
R-Zero Funding Compared to Other Biotechnology Startups
R-Zero's latest round of $105M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like R-Zero in Biotechnology and Salt Lake City
Companies Similar to R-Zero
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
R-Zero Funding FAQs
What does R-Zero do?
The first biosafety technology firm, R-Zero, is committed to making the shared indoor environments safer, healthier, and more effective. We create cutting-edge biosafety solutions that are both efficient and cutting-edge, enabling a better standard of health and safety in the built environment. To enable any firm to evaluate and manage indoor health with a new degree of sophistication and ease, we are developing the first continuous, automated disinfection ecosystem. Thousands of individuals around the nation are now safe thanks to our environmentally friendly, IoT-enabled disinfection technologies. R-Zero, which was established in April 2020, has the support of the Mayo Clinic as well as top venture capital firms and industry experts in the fields of sports, hospitality, health, and impact investing.
How much funding has R-Zero raised?
R-Zero has raised $252M across 3 rounds on record. The most recent is a Series C of $105M announced in Feb 2023.
When did R-Zero last raise funding?
R-Zero's most recent funding round on record is a Series C of $105M, announced in Feb 2023.
Who founded R-Zero?
FundedIQ lists Eli Harris (Founder) at R-Zero.
Who is the CEO of R-Zero?
Grant Morgan is listed as CEO at R-Zero.
Where is R-Zero headquartered?
R-Zero is based in Salt Lake City, Utah, United States.
How many employees does R-Zero have?
R-Zero is in the 101-250 employee band.
How does R-Zero's funding compare to other Biotechnology startups?
R-Zero's latest round of $105M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's R-Zero Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for R-Zero is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.